Collagenous endobronchial obliteration after chemoradiation followed by consolidation osimertinib: a case report.

Authors

Seunghun Lee, Juwhan Choi, Baek-Hui Kim, Hakyoung Kim, Sung Yong Lee

Published in

Frontiers in oncology. Volume 16. Pages 1895328. Epub Jul 31, 2026.

Abstract

Consolidation osimertinib after concurrent chemoradiation is a standard treatment for unresectable stage III EGFR-mutated NSCLC, but endobronchial toxicity has not been well described. To our knowledge, this is the first reported case of collagenous endobronchial obliteration after concurrent chemoradiation therapy and consolidation osimertinib.
We report an 83-year-old woman who developed acute dyspnea and complete right-lung atelectasis 3 months after completion of concurrent chemoradiation therapy while receiving consolidation osimertinib. Bronchoscopy showed membranous occlusion of all three right lobar bronchi, and biopsy demonstrated dense collagenous tissue admixed with fibrin and mild inflammation. Systemic glucocorticoid therapy and temporary interruption of osimertinib led to initial clinical improvement, but the obliteration recurred during corticosteroid tapering.
Compared with previously reported cases, our case demonstrated a more advanced fibrotic process, together with extensive involvement of all three right lobar bronchi within the irradiated field. Notably, this fibrotic change developed earlier than is typical for radiation-induced fibrosis. While radiation-induced airway injury was the principal cause, the early onset raises the possibility that osimertinib also contributed by impairing epithelial repair through EGFR inhibition.
Clinicians should be aware of the potential for collagenous endobronchial obliteration, particularly in patients with centrally located tumors receiving chemoradiation followed by consolidation osimertinib. Bronchoscopic evaluation may facilitate diagnosis, whereas systemic glucocorticoid therapy with gradual tapering and close monitoring may aid management in similar cases.

PMID:
42601977
Bibliographic data and abstract were imported from PubMed on 15 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.